| Printable Copy |
 |
| Printable Copy |
|
Meeting of the International Task Force for Disease Eradication, June 2017
https://mail.google.com/mail/u/0/#inbox/15e84b47eae4eb99
This report focuses on the viral hepatitides, especially Types B and C. Though hep B vaccine was licensed in 1982, progress against hep B and the associated liver cancer has been less rapid than was originally anticipated.